Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid

被引:80
作者
Bruce, LD
Shah, NH
Malick, AW
Infeld, MH
McGinity, JW
机构
[1] Quintiles Inc, Kansas City, MO 64137 USA
[2] Univ Texas, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA
[3] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
关键词
hot-melt extrusion; colonic drug delivery; 5-ASA; mesalamine; thermal processing; Eudragit((R)) S 100; micro-environmental pH;
D O I
10.1016/j.ejpb.2004.06.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hot-melt extruded tablets were prepared using Eudragite(R) S 100 as the polymeric carrier to target delivery of 5-aminosalicylic acid (5-ASA) to the colon. Scanning electron microscopy, modulated differential scanning calorimetry and X-ray diffraction analysis of the hot-melt tablet extrudates demonstrated that 5-ASA remained crystalline and was homogeneously dispersed throughout the polymer matrix. A pre-plasticization step was necessary,when incorporating triethyl citrate (TEC) into the formulation in order to achieve uniform mixing of the polymer and plasticizer. effectively reduce the polymer glass transition temperature (T-g), and to lower the processing temperatures. The concentration of TEC in the extrudates not only influenced the processing temperature, but also influenced the drug release rates from the extruded tablets due to leaching of the TEC during dissolution testing. Citric acid monohydrate was found to plasticize Eudragit(R) S 100, and when combined with TEC in the powder blend, the temperatures required for processing were reduced. Tablets containing citric acid released drug at a slower rate as a result of the suppression of polymer ionization due to a decrease in the micro-environmental pH of the tablet. The drug release profiles of the extruded tablets were found to fit both diffusion and surface erosion models. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:85 / 97
页数:13
相关论文
共 28 条
[1]   Hot melt extrusion of acrylic films [J].
AitkenNichol, C ;
Zhang, F ;
McGinity, JW .
PHARMACEUTICAL RESEARCH, 1996, 13 (05) :804-808
[2]  
[Anonymous], CONTROLLED RELEASE D
[3]  
AZADKHAN AK, 1977, LANCET, V2, P295
[4]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[6]  
Dangel C., 2000, PHARM TECH MAR, P64
[7]  
DANGEL C, 2000, PHARM TECH APR, P36
[8]  
DEALY J, 1990, MELT RHEOLOGY ITS RO, P441
[9]   INVESTIGATION OF FACTORS INFLUENCING RELEASE OF SOLID DRUG DISPERSED IN INERT MATRICES [J].
DESAI, SJ ;
SIMONELL.AP ;
HIGUCHI, WI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (10) :1459-&
[10]   AN ORAL PREPARATION TO RELEASE DRUGS IN THE HUMAN-COLON [J].
DEW, MJ ;
HUGHES, PJ ;
LEE, MG ;
EVANS, BK ;
RHODES, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :405-408